Startseite UR
Einträge von Fante, Matthias auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 8.
2024
Denk, Alexander 
, Mittermaier, Cornelia, Weber, Daniela, Fante, Matthias, Güneş, Sibel, Edinger, Matthias, Herr, Wolfgang und Wolff, Daniel
(2024)
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis.
Annals of Hematology 103, S. 3755-3764.
Denk, Alexander , Edinger, Matthias, Weber, Daniela, Holler, Ernst, Fante, Matthias, Meedt, Elisabeth, Gunes, Sibel, Poeck, Hendrik, Mittermaier, Cornelia, Herr, Wolfgang und Wolff, Daniel
(2024)
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis.
Annals of Hematology 103, S. 3071-3081.
2022
Kayser, Sabine, Sartor, Chiara, Luskin, Marlise R. , Webster, Jonathan, Giglio, Fabio, Panitz, Nydia, Brunner, Andrew M., Fante, Matthias, Lutz, Christoph, Wolff, Daniel, Ho, Anthony D., Levis, Mark J., Schlenk, Richard F. und Papayannidis, Cristina
(2022)
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica 107 (9), S. 2064-2071.
Volltext nicht vorhanden.
, Webster, Jonathan, Giglio, Fabio, Panitz, Nydia, Brunner, Andrew M., Fante, Matthias, Lutz, Christoph, Wolff, Daniel, Ho, Anthony D., Levis, Mark J., Schlenk, Richard F. und Papayannidis, Cristina
(2022)
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica 107 (9), S. 2064-2071.
Volltext nicht vorhanden.
2021
Wertheimer, Tobias , Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias und Wolff, Daniel
(2021)
Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis.
Annals of Hematology 100, S. 779-787.
2019
Renner, Kathrin , Bruss, Christina, Schnell, Annette, Koehl, Gudrun, Becker, Holger M., Fante, Matthias, Menevse, Ayse-Nur, Kauer, Nathalie, Blazquez, Raquel, Hacker, Lisa, Decking, Sonja-Maria, Bohn, Toszka, Faerber, Stephanie, Evert, Katja, Aigle, Lisa, Amslinger, Sabine, Landa, Maria, Krijgsman, Oscar, Rozeman, Elisa A., Brummer, Christina, Siska, Peter J., Singer, Katrin, Pektor, Stefanie, Miederer, Matthias, Peter, Katrin, Gottfried, Eva, Herr, Wolfgang, Marchiq, Ibtisam, Pouyssegur, Jacques, Roush, William R., Ong, SuFey, Warren, Sarah, Pukrop, Tobias , Beckhove, Philipp , Lang, Sven A., Bopp, Tobias, Blank, Christian U., Cleveland, John L., Oefner, Peter J., Dettmer, Katja , Selby, Mark und Kreutz, Marina
(2019)
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy.
Cell Reports 29 (1), 135-150.e9.
2018
Renner, Kathrin, Seilbeck, Anton, Kauer, Nathalie, Ugele, Ines, Siska, Peter J., Brummer, Christina, Bruss, Christina, Decking, Sonja-Maria, Fante, Matthias, Schmidt, Astrid, Hammon, Kathrin, Singer, Katrin, Klobuch, Sebastian, Thomas, Simone , Gottfried, Eva, Peter, Katrin und Kreutz, Marina
(2018)
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells.
Frontiers in Pharmacology 9 (1258), S. 1-13.
Fante, Matthias
(2018)
Impact of an anti-metabolic therapy on leukemic and non-malignant T cells.
Dissertation, Universität Regensburg.
2015
Renner, Kathrin, Geiselhöringer, Anna-Lena, Fante, Matthias, Bruss, Christina, Färber, Stephanie, Schönhammer, Gabriele, Peter, Katrin, Singer, Katrin, Andreesen, Reinhard, Hoffmann, Petra, Oefner, Peter J., Herr, Wolfgang und Kreutz, Marina
(2015)
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions.
Eur J Immunol 45 (9), S. 2504-2516.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707